BCL2 and neoplasm: Dual targeting on the apoptotic resistance machinery of tumor cells with anti-apoptotic Bcl-2 family proteins and SERCA proteins has been suggested in the past by experiments performed in leukemic cell lines, including Jurkat cells [128].